new
   Indications for Dimethyl Fumarate (Tecfidera)
507
Oct 28, 2025

Dimethyl Fumarate (Tecfidera) is an oral medication approved by the U.S. FDA for the treatment of relapsing forms of multiple sclerosis (MS). As a delayed-release capsule, it regulates the immune response through a unique pharmacological mechanism.

Indications for Dimethyl Fumarate (Tecfidera)

Primary Indications

Dimethyl Fumarate is indicated for the treatment of relapsing multiple sclerosis (RMS) in adults.

Clinically Isolated Syndrome (CIS).

Relapsing-Remitting Multiple Sclerosis (RRMS).

Active Secondary Progressive Multiple Sclerosis (SPMS).

Key Instructions

Patient Selection: Patients must be clearly diagnosed with the aforementioned relapsing forms of MS; it is not indicated for primary progressive multiple sclerosis (PPMS).

Age Restriction: The safety and efficacy of this medication in patients under 18 years of age have not been established.

Treatment Goals: Reduce the frequency of clinical relapses and the activity of MRI lesions, and delay the progression of disability.

Dosage Forms and Characteristics of Dimethyl Fumarate (Tecfidera)

120mg Capsules

Appearance: Green cap and white body, with black printing of "BG12 120mg" on the capsule body.

Use: Initial dose for the first 7 days of treatment (1 capsule twice daily).

240mg Capsules

Appearance: Fully green capsule body, with black printing of "BG-12 240mg" on it.

Use: Maintenance dose starting from day 8 (1 capsule twice daily).

Dosage Form Features

Delayed-Release Technology: Ensures the active ingredient is released in the intestinal tract, reducing gastric irritation.

Administration Requirement: Swallow the capsule whole; do not chew, crush, or sprinkle the contents on food.

Storage Methods for Dimethyl Fumarate (Tecfidera)

Temperature Requirement

Store at 15°C to 30°C (59°F to 86°F). Avoid freezing or exposure to high temperatures (e.g., inside a car, bathroom).

Light and Moisture Protection

Keep the capsules in their original bottle to avoid exposure to light and humid environments.

The desiccant inside the bottle must be retained; do not remove or ingest it.

Safe Storage

Store in a place out of the reach of children and pets, and use child-resistant bottle caps.

Handling of Special Cases: If the capsules change color, become damaged, or the desiccant container swells, discard the product immediately and contact a pharmacist.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Canakinumab (Ilaris): Dosage and Administration, Precautions, and Healthy Lifestyle

Canakinumab is an IL-1β inhibitor used for the treatment of various autoinflammatory diseases.

I. Dosage and...

Friday, April 17th, 2026, 10:36
Canakinumab (Ilaris): Side Effects, Management Strategies and Storage Instructions

Canakinumab is an IL-1β inhibitor indicated for various autoinflammatory diseases.

I. Common Side Effects of...

Friday, April 17th, 2026, 10:32
Selpercatinib (Retevmo): Dosage, Precautions, and Healthy Living

Selpercatinib (Retevmo) is an oral, precision-targeted antineoplastic agent that selectively inhibits the RET driver...

Thursday, April 16th, 2026, 11:47
Selpercatinib (Retevmo): Side Effects, Management Strategies, and Storage Guidelines

Selpercatinib (Retevmo) demonstrates significant efficacy in the treatment of various RET-driven tumors, yet it may...

Thursday, April 16th, 2026, 11:32
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved